3. Maternal complications following induction of labour in outpatient setting.
| Maternal complications | |
| Intracervical PGE₂ | |
| Larmon 2002 | 4/41 PGE, 10/43 placebo group with complication such as endometritis, chorioamnionitis and pre‐eclampsia |
| Lien 1998 | 6/43 PGE, 3/47 placebo group with complication such as endometritis and chorioamnionitis |
| McKenna 1999 | 1/30 PGE with PPH, 0/31 placebo group 2/30 PGE, 2/31 placebo group with infection |
| Rayburn 1999 | 8/143 PGE, 7/151 control (no treatment) with endometritis |
| Total | 21/257 PGE₂, 22/272 control with maternal complications |
| Oral misoprostol | |
| Gaffaney 2009 | 8/43 misoprostol group, 9/44 placebo group with chorioamnionitis 1/43 misoprostol group, 2/44 placebo group with endometritis 2/43 misoprostol group, 0/44 placebo group with PPH |
| Total | 11/43 misoprostol group, 11/44 placebo group with maternal complications |
| IMN | |
| Bollapragada 2006a | Blood loss > 500 mL: 59/177 IMN, 47/173 placebo group |
| Bullarbo 2007 | Blood loss > 1000 mL: 14/100 IMN, 12/100 placebo group |
| Habib 2008 | PPH: 2/51 IMN, 3/51 placebo group |
| Agarwal 2012 | 2/100 IMN group, 3/100 placebo group with PPH |
| Ghanaie 2013 | 0/36 IMN group, 0/36 placebo group with need for blood transfusion |
| Schmitz 2014 | 0/678 IMN group, 0/684 placebo group for maternal death 124/678 IMN group, 112/684 placebo group for PPH 20/678 IMN group, 13/684 placebo group for severe PPH 1/678 IMN group, 0/684 placebo group for deep vein thrombosis |
| Total | 202/1142 IMN group, 204/1148 placebo group with maternal complications |
| Outpatient amniotomy | |
| Rijnders 2011 | 26/270 amniotomy group, 29/251 routine care group ‐ mother treated with antibiotics |
PPH: postpartum haemorrhage